Insider Trading History of Shearman Mark S

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Shearman Mark S since 2016. This trader's CIK number is 1643799. At the time of last reporting, Shearman Mark S was the EVP, CHIEF SCIENTIFIC OFFICER of Editas Medicine, Inc.. (stock ticker symbol EDIT). Also see all insider trading activities at Editas Medicine, Inc..

Note that in the past Shearman Mark S also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Applied Genetic Technologies Corp (AGTC) by Shearman Mark S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 AGTC 0 $0 3,000 $10,053 0 $0
2016 AGTC 3,000 $26,604 0 $0 0 $0

Yearly summary of insider trading at Editas Medicine, Inc. (EDIT) by Shearman Mark S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 EDIT 0 $0 2,790 $26,965 0 $0
2022 EDIT 0 $0 5,145 $51,743 0 $0


Insider trading activities at 2 companies by Shearman Mark S:

1. Applied Genetic Technologies Corp (AGTC)

2. Editas Medicine, Inc. (EDIT)

Table 1. Insider trading of Applied Genetic Technologies Corp (AGTC) by Shearman Mark S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-12-14 AGTC Sale 3,000 3.35 10,053
2016-09-22 AGTC Buy 3,000 8.87 26,604

Table 2. Insider trading of Editas Medicine, Inc. (EDIT) by Shearman Mark S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-02-13 EDIT Sale 2,790 9.66 26,965
2022-06-15 EDIT Sale 5,145 10.06 51,743

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shearman Mark S (EVP, CHIEF SCIENTIFIC OFFICER of Editas Medicine, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.